Kyungbo Pharmaceutical Obtains International Standard ISO 37001 Certification for Anti-Bribery Management System
Kyungbo Pharmaceutical announced on April 8 that it held a certification award ceremony for the international anti-bribery management system standard 'ISO37001' at its Seoul office in Seodaemun-gu, Seoul.
ISO37001 is an international standard established in 2016 by the International Organization for Standardization (ISO) to proactively identify, control, and manage corrupt practices within organizations. Certification is granted based on a comprehensive evaluation of factors such as corruption risk assessment and the level of internal control system implementation.
At the ISO37001 certification award ceremony held on the 7th at Kyungbo Pharmaceutical's Seoul Office in Seodaemun-gu, Seoul, Kyungbo Pharmaceutical CEO Taeyoung Kim (left) and Wonki Lee, President of the Korea Compliance Certification Institute, are posing for a commemorative photo. Kyungbo Pharmaceutical
View original imageKyungbo Pharmaceutical has made company-wide efforts to establish a management system in line with international standards and to build a systematic foundation capable of proactively controlling potential legal and corruption risks. The company appointed responsible managers for each department to conduct risk assessments and has been recognized for its proactive stance in preventing corruption risks through regular compliance program training and anti-corruption education, which contributed to obtaining this certification.
Hot Picks Today
Taeyoung Kim, CEO of Kyungbo Pharmaceutical, stated, "This ISO37001 certification demonstrates Kyungbo Pharmaceutical's systematic compliance management system and enhances our corporate credibility. Going forward, we will continue to build sustainable cooperative relationships with domestic and international partners through fair and transparent partnerships and further strengthen our ethical management system in accordance with global standards."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.